Tirzepatide is the same molecule sold as Mounjaro (diabetes) and Zepbound (weight loss). Both are made by Eli Lilly. Compounded tirzepatide — same active ingredient from a 503A or 503B pharmacy — is the cash-pay version most uninsured patients can actually afford. This page covers what each version is, who it’s for, and what they actually cost in 2026.
What Tirzepatide Is
Tirzepatide is the only dual GIP/GLP-1 receptor agonist on the market. Every other GLP-1 — semaglutide, liraglutide, orforglipron — hits a single receptor. Tirzepatide hits two. That second receptor (GIP) is part of why the head-to-head SURMOUNT-5 trial showed tirzepatide produced ~21% body-weight reduction versus ~14% for semaglutide over 72 weeks.
It’s a weekly injection. Mounjaro was FDA-approved for type 2 diabetes in 2022. Zepbound got the chronic-weight-management indication in November 2023. As of 2026 it’s the most effective weight loss medication available by efficacy data — though it’s three years younger than semaglutide as a weight-loss-approved drug.
For the full class context — how tirzepatide compares to semaglutide and the newer molecules — see the full GLP-1 medication class.
Brand-Name vs Compounded Tirzepatide
Three clinically available versions in 2026:
- Mounjaro (tirzepatide injection) — FDA-approved for type 2 diabetes. Doses: 2.5, 5, 7.5, 10, 12.5, and 15 mg weekly. Insurance-covered for T2D patients; cash-pay list price ~$1,080/month.
- Zepbound (tirzepatide injection) — FDA-approved for chronic weight management. Same dose ladder. Lilly’s self-pay program (LillyDirect) sells single-dose vials at $349 (lower doses) up to $499 (higher doses) per month in 2026. Read the how to get Zepbound guide for the full route.
- Compounded tirzepatide — Made by 503A or 503B pharmacies. Cash-pay only, $149–$399/month depending on provider. The FDA officially resolved the tirzepatide shortage in late 2024 but 503A patient-specific compounding has continued; the April 30, 2026 503B Bulks List proposal could narrow availability after the June 29 comment period.
Who Tirzepatide Is For
If you want the highest-efficacy weight loss drug available right now and you can tolerate weekly injections, tirzepatide is the answer based on the head-to-head data.
It also has a clean diabetes label (Mounjaro), so if you’re prediabetic or T2D, tirzepatide pulls double duty. The SURPASS trials showed substantial A1C reductions plus weight loss.
Side effect profile is similar to other GLP-1s — nausea, constipation, fatigue in the first 4–8 weeks. The dual mechanism means slightly more reports of injection-site reactions and slightly less GI severity in some patient subgroups, but individual variation is large.
If you’re prone to severe GI side effects with semaglutide, tirzepatide is sometimes (anecdotally) better tolerated. If cost is the dominant constraint, semaglutide compounded is typically a bit cheaper.
What Tirzepatide Costs in 2026
| Path | Monthly cost | Notes |
|---|---|---|
| Zepbound via insurance | $0–$50 copay | If your plan covers it (about 40% of commercial plans do, with PA) |
| LillyDirect cash-pay Zepbound | $349–$499/mo | Vials, dose-dependent. Single-dose only — multi-dose pens not in self-pay program |
| Mounjaro via insurance (diabetes) | $0–$50 copay | T2D coverage standard |
| Compounded tirzepatide | $149–$399/mo | Cash-pay only. See the cheapest tirzepatide programs for current ranked pricing |
| Retail Zepbound without insurance | $1,080+/mo | List price; rarely the right path |
The lowest legitimate cash-pay route is compounded tirzepatide from a vetted pharmacy. The best compounded GLP-1 providers guide ranks providers by patient experience, not sticker price — refill timing, clinician response, cancellation reality, and cold-chain shipping.
How to Get Tirzepatide
Three routes:
- Through your existing doctor + insurance. Best if you have a Zepbound-covered plan. Bring your BMI numbers and comorbidity list; PA paperwork is standard for chronic-weight-management approval.
- Direct from Lilly via LillyDirect. Single-dose vials shipped directly to you, no insurance involvement. Cheapest brand-name route at $349/month for early doses.
- Through a telehealth program. Most prescribe compounded tirzepatide; a few prescribe Zepbound and assist with insurance PA. See the best telehealth GLP-1 programs for the ranked list.
For the brand-specific Zepbound path including insurance appeals and the LillyDirect 45-day refill trap, see how to get Zepbound.
What to Watch For
The 45-day refill rule. LillyDirect won’t ship a refill before day 45 from your last shipment. Plan your reorder timing or you’ll run out.
Compounded supply risk. The 503B Bulks List proposal (comment period closes June 29, 2026) could restrict 503B compounding of tirzepatide. 503A patient-specific compounding is likely to continue. If price is your driver, model what happens if 503B access shrinks: LillyDirect at $349 is the realistic fallback.
Pharmacy verification. Some “compounded tirzepatide” programs work with pharmacies that have disciplinary histories or expired licenses. Always check the named pharmacy partner and its current license status before paying.
Where Next
- Looking for the lowest price? Cheapest tirzepatide providers ranked by patient experience
- Want Zepbound specifically? How to get Zepbound: insurance, LillyDirect, and cash-pay paths
- Don’t know which GLP-1 yet? The full GLP-1 medication class guide
- Want the cheapest path across all GLP-1s? Cheapest GLP-1 medications
- No insurance? GLP-1 without insurance: 2026 cash-pay playbook